China NMPA Product Recall - Electric medical beds

Stryker Medical, through its subsidiary Stryker (Beijing) Medical Devices Co., Ltd., initiated a voluntary Class II recall of its electric medical beds, as announced by the National Medical Products Administration (NMPA) on August 18, 2020. The recall was prompted by the discovery that these medical beds, identified under Registration Certificate No.: 20192150339, had been sold to individual users in certain countries despite their design making them unsuitable for home environments. This distribution beyond their intended professional scope raised significant safety and efficacy concerns, as the products were being utilized outside their applicable parameters.The primary issue identified was a mismatch between the product's intended use and its actual distribution. Electric medical beds are typically designed for clinical or institutional settings, yet their availability to private individuals for home use presented a risk. The NMPA's regulatory framework oversees medical devices to ensure public safety and proper product application.As a required action, Stryker Medical is implementing this voluntary recall to address the misapplication of these devices. Detailed information regarding the models, specifications, and batches of affected products can be found in the attached "Medical Device Recall List" and "Medical Device Recall Event Report Form." This proactive measure aims to mitigate potential risks associated with the use of these beds in unsuitable domestic environments, reinforcing the importance of adhering to specified product applications and user guidelines within the medical device industry.